MHRA APPROVES DEPODUR FOR PAIN FOLLOWING SURGERY

A A

SkyePharma has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) approved the company's DepoDur for the treatment of pain following major surgery. DepoDur is a single-dose sustained-release injectable formulation of morphine.

Recent Phase III clinical trials of DepoDur involved more than 1000 patients in four different pain models and demonstrated the benefit of the drug in controlling post-operative pain, the company reported.